These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72. Serum lysozyme as a marker of host resistance. II. Patients with malignant melanoma, hypernephroma or breast carcinoma. Currie GA Br J Cancer; 1976 Jun; 33(6):593-9. PubMed ID: 938609 [TBL] [Abstract][Full Text] [Related]
73. Relation between the frequency of colorectal adenoma and the serum cholesterol level. Neugut AI N Engl J Med; 1987 Jul; 317(1):55-6. PubMed ID: 3587317 [No Abstract] [Full Text] [Related]
74. Increased gamma-glutamyl transferase activity in human colon cancer. Fiala S; Trout E; Pragani B; Fiala ES Lancet; 1979 May; 1(8126):1145. PubMed ID: 86867 [No Abstract] [Full Text] [Related]
75. Plasminogen activators in human colorectal neoplasia. Ramsay DA Br Med J (Clin Res Ed); 1986 Nov; 293(6556):1240-1. PubMed ID: 3096452 [No Abstract] [Full Text] [Related]
76. Plasminogen activators in human colorectal neoplasia. Gelister JSK; Lewin MR; Mahmoud M; Gaffney PJ; Boulos PB Br Med J (Clin Res Ed); 1986 Dec; 293(6560):1505-6. PubMed ID: 3099935 [No Abstract] [Full Text] [Related]
77. Chloroquine-induced inhibition of rat serum muramidase activity in vivo in relation to tissue changes. Ngaha EO Toxicol Lett; 1984 Jun; 21(3):301-4. PubMed ID: 6740718 [TBL] [Abstract][Full Text] [Related]